Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Are Antidepressants Safe and Effective in Children?

20.12.2005


Neuroscientist Takes Issue with Antidepressants for Children



The question of whether SSRI antidepressants, such as fluoxetine (Prozac), are safe and more effective than dummy pills for treating child and adolescent depression (CAD) remains highly contentious, says Dr Amir Raz, Assistant Professor of Clinical Neuroscience in the Division of Child and Adolescent Psychiatry at Columbia University and Research Scientist at the New York State Psychiatric Institute, in New York City.

Writing in the open access journal PLoS Medicine, Dr Raz says that when it comes to treating CAD, “there are few compelling data sets, free of funding from drug companies, concerning the efficacy of antidepressant medications over and above their placebo value.”


In his analysis, Dr Raz looks at some of the reasons behind the current dispute over the value of SSRI antidepressants for treating depressed children and adolescents.

“The recent history of SSRIs is replete with inconsistent verdicts about their safety,” he says. For example, despite issuing a “black box” warning label on antidepressants stating that they may increase the risk of suicidal thinking and behavior in depressed children and adolescents, the FDA went on to endorse the safety of these drugs for treating CAD.

In addressing possible implications of SSRI use for CAD, Dr Raz points to data in mouse studies suggesting that exposure to SSRIs early in life produces abnormal emotional behaviors in adults. “Some exploratory findings suggest that artificial perturbation of serotonin function in early life may alter the normal development of brain systems related to stress, motor development, and motor control.”

Another factor, says Dr Raz, that further confounds the debate over SSRIs for CAD is that while some studies have shown statistically significant effects, these effects may not be meaningful in the real world of clinical practice. Dr Irving Kirsch and Dr David Antonuccio, who gave testimony to the FDA in 2004 on the efficacy of SSRIs for CAD, also concluded that the effect of these drugs may be statistically significant, but possibly not clinically significant.

Dr Raz says that while some mental health experts “dismiss investigators such as Kirsch and Antonuccio as ‘outliers’ or inherently biased against the drug industry, such ‘outlying’ accounts should nevertheless be examined.”

Given all of the limitations surrounding the data on SSRIs, Dr Raz urges patients and physicians to “demand stronger evidence for the efficacy of antidepressants for CAD.”

Paul Ocampo | alfa
Further information:
http://www.plos.org
http://www.plosmedicine.org

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>